The question of the optimal tissue, such as biopsy, surgical specimen or tissue-micro-arrays (TMA), to assess the Ki-67 index in breast cancer is controversial and has been addressed in the literature9,10,25,26,37–39. The gene discussed is MKI67; the disease is breast carcinoma.